# Efficacy and Safety Evaluation of EASYEF® in Acute Wound (Split-thickness Skin Graft Donor Site)

> **NCT05335720** · NA · COMPLETED · sponsor: **PT. Daewoong Infion** · enrollment: 10 (actual)

## Conditions studied

- Skin Graft Scar
- Split-Thickness Skin Graft (STSG)

## Interventions

- **DRUG:** rhEGF

## Key facts

- **NCT ID:** NCT05335720
- **Lead sponsor:** PT. Daewoong Infion
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-19
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-04-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05335720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05335720, "Efficacy and Safety Evaluation of EASYEF® in Acute Wound (Split-thickness Skin Graft Donor Site)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05335720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*